Stellar Biotechnologies, Inc. Purchase Agreements
5 Contracts & Agreements
- Form of Securities Purchase Agreement, dated March 21, 2022, by and between the Company and the Purchaser (Filed With SEC on March 23, 2022)
- Securities Purchase Agreement by and between Edesa Biotech, Inc. and NovImmune SA dated April 17, 2020 (Filed With SEC on April 23, 2020)
- Purchase Agreement by and between Edesa Biotech Research, Inc. and NovImmune SA dated April 17, 2020 (Filed With SEC on April 23, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on May 15, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on May 8, 2018)
